Skip to content

Melanoma/Skin Cancer Health Center

Font Size

Melanoma Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Stage I Melanoma

Stage I melanoma is defined by the American Joint Committee on Cancer's TNM classification system:[1]

  • T1a, N0, M0
  • T1b, N0, M0
  • T2a, N0, M0

Standard Treatment Options for Patients With Stage I Melanoma

Recommended Related to Melanoma/Skin Cancer

Understanding Skin Cancer -- Prevention

If you are at risk for skin cancer, take the following precautions whenever possible: Avoid intense sun exposure by staying out of it from 10 a.m. to 2 p.m.. Outside, wear a hat with a brim, long sleeves, trousers, and sunglasses that block UV radiation. Use UPF (Ultraviolet Protection Factor) clothing. Or use Rit Sun Guard Laundry Treatment UV Protectant. Use a sunscreen with a sun protection factor (SPF) of 30 or higher whenever you are outside. Report suspicious skin lesions to...

Read the Understanding Skin Cancer -- Prevention article > >

  • Current evidence suggests that lesions 2 mm or less in thickness may be treated conservatively with radial excision margins of 1 cm. A randomized trial compared narrow margins (1 cm) with wide margins (at least 3 cm) in patients with melanomas no thicker than 2 mm.[2,3] No difference was observed between the two groups in respect to the development of metastatic disease, disease-free survival (DFS), or overall survival (OS). Two other randomized trials compared 2 cm margins with wider margins (i.e., 4 cm or 5 cm) and found no statistically significant difference in local recurrence, distant metastasis, or OS with a median follow-up of 10 years or more for both trials.[4,5,6][Level of evidence:1iiA] In the Intergroup Melanoma Surgical Trial, the reduction in margins from 4 cm to 2 cm was associated with a statistically significant reduction in the need for skin grafting (46% to 11%, P < .001) and a reduction in the length of the hospital stay.[6] Depending on the location of the melanoma, most patients can now have this procedure performed on an outpatient basis.

    Elective regional lymph node dissection is of no proven benefit for patients with stage I melanoma. Lymphatic mapping and sentinel lymph node (SNL) biopsy for patients who have tumors of intermediate thickness and/or ulcerated tumors, however, may allow the identification of individuals with occult nodal disease who might benefit from regional lymphadenectomy and adjuvant therapy.[7,8,9,10]

    The International Multicenter Selective Lymphadenectomy Trial (MSLT-1 [JWCI-MORD-MSLT-1193]) included 1,269 patients with intermediate-thickness (defined as 1.2 mm–3.5 mm in this study) primary melanomas.[11] There was no melanoma-specific survival advantage (the primary endpoint) for those patients randomly assigned to wide excision plus SLN biopsy followed by immediate complete lymphadenectomy for node positivity versus patients randomly assigned to nodal observation and delayed lymphadenectomy for subsequent nodal recurrence at a median of 59.8 months.[11][Level of evidence: 1iiB]

    This trial was not designed to detect a difference in the impact of lymphadenectomy in patients with microscopic lymph node involvement.[11]

    1|2
    Next Article:

    Today on WebMD

    Malignant melanoma
    About 40-50 percent of those who live to be 65 may get it. Here’s how to spot early.
    Woman checking out tan lines
    There’s a dark side to that strive for beauty. See them here.
     
    sauteed cherry tomatoes
    Fight cancer one plate at a time.
    Lung cancer xray
    See it in pictures, plus read the facts.
     
    12 Ways to Protect Your Skin from Melanoma
    ARTICLE
    precancerous lesions slideshow
    SLIDESHOW
     
    Do You Know Your Melanoma ABCs
    VIDEO
    15 Cancer Symptoms Men Ignore
    ARTICLE
     
    screening tests for men
    SLIDESHOW
    Vitamin D
    SLIDESHOW
     
    Is That Mole Skin Cancer
    VIDEO
    Brilliant sun rays
    Quiz
     

    WebMD Special Sections